Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT7MRGU)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Pancrecarb	DMOML9Q	Pancreatic malfunction	DC30-DC3Z	NDA filed	[1]
CM-AT	DMLMN2F	Attention deficit hyperactivity disorder	6A05.Z	Phase 3	[2]
Liprotamase	DMNF4UH	Cystic fibrosis	CA25	Phase 3	[3]
------------------------------------------------------------------------------------

2 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
JBP-1	DM0KMPN	Solid tumour/cancer	2A00-2F9Z	Investigative	[1]
POP-1	DMVTKCX	Solid tumour/cancer	2A00-2F9Z	Investigative	[1]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	US patent application no. 2012,0251,516, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT.
2	Drugmakers dance with autism. Nat Biotechnol. 2010 Aug;28(8):772-4.
3	Clinical pipeline report, company report or official report of Anthera Pharmaceuticals.